Jean-Jacques Body

5PUBLICATIONS
30CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Sport and exercise nutritionBiomechanics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 18, 2026
A Randomized Phase 1 Study Comparing the PK, PD, Safety, and Immunogenicity of Proposed Biosimilar RGB-14-X and Denosumab in Healthy Adult Males.

Emmanuel Biver, Jean-Jacques Body, Ashwin Sachdeva

|Jan 12, 2026
Non-metastatic breast cancer patients discontinuing aromatase inhibitor on denosumab: what next?

G Marcucci, E Biver, J J Body

|Aug 10, 2024
When and How to Evaluate Vitamin D Status? A Viewpoint from the Belgian Bone Club.

Bruno Lapauw, Michaël R Laurent, Serge Rozenberg

|Jun 01, 2020
Efficacy of teriparatide compared with risedronate on FRAX®-defined major osteoporotic fractures: results of the VERO clinical trial.

J-J Body, F Marin, D L Kendler

Pageof 1